Translating curcumin into clinical practice for treatment of metastatic colorectal cancer : the CUFOX trial
Palliative treatment of metastatic colorectal cancer provides an overall median survival rate of approximately 21 months, with response rates of less than 60%. Curcumin is a low molecular weight polyphenol derived from the spice turmeric that inhibits carcinogenesis in vitro and in vivo via multi-ta...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
University of Leicester
2017
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.713373 |